PROMO!
First order? Get 10% OFF with this code: 1storder
MGF (Mechano Growth Factor) is a peptide variant derived from alternative splicing of the IGF-1 gene. It is investigated in laboratory research for its molecular characteristics, peptide structure, and interactions within IGF-associated cellular signaling pathways.
MGF, which is usually known as Mechano Growth Factor, is a peptide linked to an alternatively spliced form of the IGF-1 (insulin-like growth factor 1) gene. In the scientific literature, MGF is most often talked about in connection with the E-domain sequence resulting from the IGF-1Ec/IGF-1Eb splice variants, the exact naming depending on the species. Since the terminology differs from one publication to another, it is necessary to separate the peptide sequence derived from MGF from that of the full-length IGF-1 isoforms.
Experimental research has concentrated on the molecular features, expression patterns, and signalling properties of peptides related to MGF in controlled laboratory settings. The studies have looked at how alternative splicing of IGF-1 affects the structure of the resulting propeptide and have also examined whether sequences derived from the E domain can show biological activities different from those of mature IGF-1. Furthermore, the research looks into whether these peptides interact with cellular pathways without going through the usual IGF-1 receptor mechanism, although the exact molecular targets are still the subject of ongoing investigation.
MGF is primarily relevant as a research peptide for studying IGF-1 splice variants, E-domain biology, peptide signaling, and structure–function relationships under controlled experimental conditions.
The E-domain of an alternatively spliced isoform of IGF-1, known as IGF-1Ec in humans, contains MGF (Mechano Growth Factor). A 49 base pair segment is added as a result of the alternative splicing, which shifts the reading frame and creates a unique C-terminal region that differs from that of the other human IGF-1 isoforms.
In the field of experimental peptide research, MGF usually denotes a synthetic peptide which corresponds to the particular 24-amino-acid C-terminal section of the human MGF E-domain (called the MGF-E peptide). This is a linear peptide composed of a mix of polar, charged and hydrophobic amino acids, one of which is a polybasic region rich in arginine and lysine. Moreover, studies have found certain conserved sequence characteristics in the E-domain, among them a region with a serine residue that has been looked at as a possible phosphorylation-associated motif.
It is important to differentiate the 24-amino-acid research peptide derived from MGF from the complete IGF-1Ec propeptide; this distinction is relevant when giving information on molecular characteristics, analytical specifications and experimental results since the literature at times refers to 'MGF' when describing both the full splice isoform and the isolated E-domain-derived peptide.
The MGF (Mechano Growth Factor) peptide is mainly being studied for the cellular signalling characteristics linked to the E-domain of the IGF-1 splice variants. Experimental research involving synthetic MGF E-peptides has shown activation of the ERK1/2 (MAPK) signalling pathway, though activation of the Akt pathway has not been consistently seen.
The exact receptor mechanism is still not settled in the scientific literature. Some experimental studies have shown that the activity of synthetic MGF E-peptide continues even when the IGF-1 receptor (IGF-1R) is blocked or silenced, indicating a mechanism different from conventional IGF-1R signalling. Yet in other research it has been reported that MAPK signalling associated with IGF-1 E-peptide can rely on a functional IGF-1R and may involve alterations in receptor availability rather than direct receptor activation.
It is important to note that full-length MGF and the isolated synthetic MGF E-peptide are not mechanistically equivalent since full-length MGF has shown direct activation of IGF-1R in receptor assays, while the isolated MGF E-peptide did not display the same activity.
As a result, MGF is still undergoing investigation as a model for the study of IGF-1 alternative splicing, E-domain signalling, ERK/MAPK pathway activity and peptide–receptor interactions. However, no definite independent receptor for the MGF E-peptide has yet been identified.
This summary reflects findings reported in published preclinical and in vitro research. The original studies supporting this information are listed in the references.
Research related to MGF looks at the alternative splicing of the IGF-1 gene and the resulting isoforms that contain the E-domain. In humans, the transcript usually linked with MGF is called IGF-1Ec. Experimental studies look into how the expression of these splice variants varies under different mechanical and cellular conditions. Moreover, the literature treats IGF-1Ec expression as distinct from that of the isolated synthetic MGF E-peptide.
The intracellular signalling mechanisms are being studied using cellular models involving synthetic MGF E-peptides. Research has looked at pathways such as ERK/MAPK signalling and has investigated whether the observed responses take place independently of, or involve interactions with, the classical IGF-1 receptor pathway. However, the exact molecular mechanism is still not completely understood and is a matter of ongoing investigation.
Peptides derived from the E-domain of MGF have been looked at in experiments involving cell migration. For instance, experiments carried out using human mesenchymal stem cells and C2C12 cells have examined the effects on chemotaxis or transwell migration after exposure to peptides derived from MGF. Such models are useful for the study of cell responses that are dependent on peptides under controlled experimental conditions.
The research carried out by MGF involves the use of cultured muscle cells and progenitor cell systems in order to study processes such as proliferation, differentiation, and cellular fusion. The results depend on the peptide construct, the cell type and the experimental conditions, which shows how important it is to distinguish between full-length IGF-1Ec and synthetic MGF E-domain peptides when interpreting the findings.
The researchers also compare the IGF-1Ec, the mature IGF-1 and the isolated MGF E-domain sequences in order to find out how the various molecular regions contribute to the cellular responses observed. Experiments of this kind have shown that the isolated MGF E-peptide does not always exhibit the same behaviour as the complete IGF-1Ec molecule.
A major area of research is concerned with whether a stable endogenous peptide which corresponds to the synthetic MGF E-peptide is naturally produced from IGF-1 precursors. Reviews of the evidence have pointed out that a similar stable 24-amino-acid peptide has not yet been definitively isolated from biological systems. As a result, the connection between synthetic MGF research peptides and the endogenous processing of IGF-1 is still an open scientific question.
The identity, purity and molecular integrity of MGF peptide are usually checked using a number of complementary methods. Liquid chromatography (LC/HPLC) is able to separate the desired peptide from other related substances, and mass spectrometry (MS) gives precise molecular-mass and fragmentation data which are used to confirm identity. In the published research on MGF, high-resolution MS and tandem MS have been used to identify MGF-related sequences and structural modifications. The batch-specific purity and identity must be supported by the relevant Certificate of Analysis (COA) and by validated analytical data.
MGF peptide should be stored under controlled laboratory conditions to limit exposure to moisture, temperature variations and degradation. Store MGF peptide at 2–8°C in accordance with the applicable product specifications.
Solution stability depends on factors such as solvent composition, concentration, temperature, and experimental conditions. Repeated freeze–thaw cycles may affect peptide integrity.
Storage requirements may vary by peptide construct and batch. Refer to the batch-specific Certificate of Analysis, Safety Data Sheet (SDS), and applicable manufacturer storage instructions for the current material.
MGF, also known as Mechano Growth Factor, is linked to an alternatively spliced isoform of IGF-1; in the field of peptide research, the term "MGF peptide" usually denotes a synthetic peptide that corresponds to the particular C-terminal 24-amino-acid segment of the human IGF-1Ec E-domain.
MGF is directly connected with the IGF-1 gene and its alternative splicing; human IGF-1Ec has a particular E-domain which results from alternative splicing, whereas the synthetic MGF E-peptide used in experiments consists of part of that region and not of mature IGF-1 itself.
The C-terminal section of the IGF-1 precursor is the part which varies among the different IGF-1 splice variants, and the IGF-1Ec found in humans has a particular E-domain; a synthetic peptide based on the last 24 amino acids of this peptide has been extensively used in studies of the molecular properties linked to this sequence.
IGF-1Ec is a complete splice variant of IGF-1, while the synthetic MGF E-peptide which is commonly studied consists only of a particular 24-amino-acid section of its E-domain; it must therefore be regarded as not being the same as IGF-1Ec, and a stable endogenous 24-residue peptide equivalent has not yet been clearly demonstrated.
Experimental studies have examined MGF-derived peptides with regard to ERK/MAPK signaling and other intracellular pathways. Although some studies indicate that their signaling properties are different from those resulting from classical IGF-1 receptor activation; the exact receptor and molecular mechanism involved in the isolated MGF E-peptide are still not resolved.
Research Use exclusively: MGF peptide is exclusively provided for analytical and laboratory research. It is not for human consumption or veterinary use and is not intended for administration. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Information on this page is provided for scientific research purposes only.
